Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2979 (LINC02979)
- Target
- LINC02979
- Molecular classification
- lncRNA, long non-coding RNA
01
Overview
Long intergenic non-protein coding RNA 2979 (LINC02979) is a human gene that encodes a long non-coding RNA, not a protein. It is catalogued in major genomic databases (HGNC, NCBI Gene, Ensembl) and also known as RP11-703I16.1[5][9][11]. LINC02979 belongs to the molecular class of lncRNAs (long non-coding RNAs), a large non-protein coding RNA family that modulate gene expression, influence epigenetic processes, and have been broadly implicated in various human diseases, most notably cancer progression and regulation[13]. However, there are no curated experimental studies or disease associations specifically describing the function, disease relevance, or interaction profile of LINC02979[3][5][9]. It is not currently recognized or validated as a therapeutic target, nor are there known drugs, biomarkers, or safety concerns related to this gene or transcript. Its biological roles remain to be elucidated in future research.
- Other names
- LINC02979RP11-703I16.1HGNC:56043NCBI Gene: 123706539Ensembl: ENSG00000267480
02
Mechanism of action
null
03
Biological functions
There is no specific curated biological function for LINC02979; lncRNAs generally regulate gene expression, epigenetic states, and can interact with protein complexes, but function is molecule-specific and most lncRNAs are yet to be functionally characterized
04
Disease associations
No published associations specific to LINC02979 with any disease found in key curated databases or GWAS results as of the latest updatesIn general, lncRNAs as a class are implicated in cancer, inflammation, and other disorders, but there is no documented role for LINC02979 in any specific disease
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2979 (LINC02979).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2979 (LINC02979).